Drug company stocks are soaring
Drug stocks are soaring Wednesday, after Democratic presidential candidate Hillary Clinton, who had outlined plans to to curb drug price increases was defeated by Republican Donald Trump.
Biotech investors had been skittish about what a Clinton presidency would mean, and she often sent drugmakers' stocks falling with her comments. Trump has been less focused on the issue of drug pricing, though he has suggested the US import cheaper drugs and called for Medicare to be able to negotiate drug prices.
The news, coupled with the defeat of a California ballot measure that would have limited prices on some prescriptions in the state, has sent shares of the drug industry soaring. The NASDAQ biotechnology index was up 8% early Wednesday.
Google Finance
The top 10 companies that donated to the California ballot measure are all up. Here's a rundown:
- Merck & Co. - 6.5%
- Pfizer - 11%
- Johnson & Johnson - 4.4%
- Amgen - 10%
- AbbVie - 9.6%
- Sanofi-Aventis - 4.6%
- AstraZeneca -3.6%
- Allergan - 11.43%
- Novartis - 4%
- GlaxoSmithKline -3.4%
Visit Markets Insider for constantly updated market quotes for individual stocks, ETFs, indices, commodities and currencies traded around the world. Go Now!
- A centenarian who starts her day with gentle exercise and loves walks shares 5 longevity tips, including staying single
- A couple accidentally shipped their cat in an Amazon return package. It arrived safely 6 days later, hundreds of miles away.
- FSSAI in process of collecting pan-India samples of Nestle's Cerelac baby cereals: CEO
- Private Equity Investments
- Having an regional accent can be bad for your interviews, especially an Indian one: study
- Dirty laundry? Major clothing companies like Zara and H&M under scrutiny for allegedly fuelling deforestation in Brazil
- 5 Best places to visit near Darjeeling
- Climate change could become main driver of biodiversity decline by mid-century: Study